Horizon Pharma (Nasdaq: HZNP) issued a statement denying allegations that it owned specialty pharmacies that sold its products and clarifying that the average prices of DUEXIS, VIMOVO, PENNSAID and RAYOS have not increased over the past year. The stock price soared $3.94 to close at $17.06.
Horizon denies allegations
October 23, 2015 at 18:28 PM EDT
